Procter & Gamble Q2 Adj EPS $1.84 Beats $1.70 Estimate, Sales $21.44B Miss $21.47B Estimate
Portfolio Pulse from Benzinga Newsdesk
Procter & Gamble (PG) reported Q2 adjusted EPS of $1.84, surpassing the $1.70 estimate, marking a 15.72% increase from last year. However, sales of $21.44B slightly missed the $21.47B estimate, though they were up 3.22% from the previous year.
January 23, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Procter & Gamble's Q2 earnings beat estimates with an EPS of $1.84, but sales slightly missed expectations at $21.44B.
The EPS beat is a positive signal of financial health and efficiency, which investors generally view favorably. However, the slight miss in sales could indicate a potential slowdown in revenue growth or market challenges, which may temper investor enthusiasm. The mixed results lead to a neutral short-term impact score, as the positive EPS may balance out concerns over the sales miss.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100